Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PainChek Ltd ( (AU:PCK) ) has provided an announcement.
PainChek Ltd has announced the issuance of 218,823,533 fully paid ordinary shares to sophisticated and professional investors without disclosure under the Corporations Act. This strategic move is aimed at strengthening the company’s financial position and enhancing its market presence. The issuance has been conducted in compliance with relevant legal provisions, and there is no undisclosed information that needs to be shared with investors. This development is expected to bolster PainChek’s operational capabilities and support its expansion into new markets, particularly in home care and disability services.
More about PainChek Ltd
PainChek Ltd is a company operating in the medical device industry, known for its innovative PainChek® app. This app is the world’s first regulatory-cleared medical device for pain assessment, designed to assist in pain management for individuals who cannot reliably self-report their pain. The app is available on smartphones and tablets, utilizing AI to automate pain assessment and is globally recognized in regions including Australia, Canada, the EU, and more. PainChek has partnerships with over 1,800 aged care facilities and has conducted over 12 million digital pain assessments.
Average Trading Volume: 1,795,490
Technical Sentiment Signal: Hold
Current Market Cap: A$64.47M
Learn more about PCK stock on TipRanks’ Stock Analysis page.